TuHURA Biosciences Inc. (HURA)
NASDAQ: HURA
· Real-Time Price · USD
3.94
-0.16 (-3.90%)
At close: May 14, 2025, 3:09 PM
-3.90% (1D)
| Bid | 3.69 |
| Market Cap | 172.1M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -10.84M |
| EPS (ttm) | -1.21 |
| PE Ratio (ttm) | -3.26 |
| Forward PE | -4.45 |
| Analyst | Buy |
| Ask | 4.17 |
| Volume | 61,244 |
| Avg. Volume (20D) | 208,195 |
| Open | 4.07 |
| Previous Close | 4.10 |
| Day's Range | 3.88 - 4.10 |
| 52-Week Range | 1.80 - 14.60 |
| Beta | 0.52 |
About HURA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol HURA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for HURA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+19.59%
TuHURA Biosciences shares are trading higher on po...
Unlock content with
Pro Subscription
1 month ago
+15.7%
TuHURA Biosciences shares are trading higher after the company announced it acquired Kineta.
2 months ago · accessnewswire.com
TuHURA Biosciences, Inc. to Present at the 37th Annual ROTH ConferenceLive webcast fireside chat on Tuesday, March 18th at 8:30 AM PT TAMPA, FL / ACCESS Newswire / March 10, 2025 / TuHURA Biosciences, Inc. (NASDAQ:HURA) ("TuHURA"), a Phase 3 registration-stage immuno-on...
2 months ago · accessnewswire.com
TuHURA Biosciences, Inc. Participates in the Virtual Investor “Top 5 for ‘25” On-Demand ConferenceOn-demand video webcast now available here TAMPA, FL / ACCESS Newswire / February 19, 2025 / TuHURA Biosciences, Inc. (NASDAQ:HURA) ("TuHURA"), a Phase 3 registration-stage immune-oncology company dev...